Your browser doesn't support javascript.
loading
Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations.
Golmard, L; Delnatte, C; Laugé, A; Moncoutier, V; Lefol, C; Abidallah, K; Tenreiro, H; Copigny, F; Giraudeau, M; Guy, C; Barbaroux, C; Amorim, G; Briaux, A; Guibert, V; Tarabeux, J; Caputo, S; Collet, A; Gesta, P; Ingster, O; Stern, M-H; Rouleau, E; de Pauw, A; Gauthier-Villars, M; Buecher, B; Bézieau, S; Stoppa-Lyonnet, D; Houdayer, C.
Afiliação
  • Golmard L; Institut Curie, Département de Biopathologie, Paris, France.
  • Delnatte C; Institut Curie, Inserm U830, Paris, France.
  • Laugé A; CHU Nantes, Service de Génétique médicale, Nantes, France.
  • Moncoutier V; Institut Curie, Département de Biopathologie, Paris, France.
  • Lefol C; Institut Curie, Département de Biopathologie, Paris, France.
  • Abidallah K; Institut Curie, Département de Biopathologie, Paris, France.
  • Tenreiro H; Institut Curie, Département de Biopathologie, Paris, France.
  • Copigny F; Institut Curie, Département de Biopathologie, Paris, France.
  • Giraudeau M; Institut Curie, Département de Biopathologie, Paris, France.
  • Guy C; Institut Curie, Département de Biopathologie, Paris, France.
  • Barbaroux C; Institut Curie, Département de Biopathologie, Paris, France.
  • Amorim G; Institut Curie, Département de Biopathologie, Paris, France.
  • Briaux A; Institut Curie, Département de Biopathologie, Paris, France.
  • Guibert V; Institut Curie, Département de Biopathologie, Paris, France.
  • Tarabeux J; CHU Nantes, Service de Génétique médicale, Nantes, France.
  • Caputo S; Institut Curie, Département de Biopathologie, Paris, France.
  • Collet A; Institut Curie, Inserm U830, Paris, France.
  • Gesta P; Institut Curie, Département de Biopathologie, Paris, France.
  • Ingster O; Institut Curie, Département de Biopathologie, Paris, France.
  • Stern MH; Pôle Oncologie, Oncogénétique Poitou-Charentes, Niort, France.
  • Rouleau E; CHU Angers, Service de Génétique médicale, Angers, France.
  • de Pauw A; Institut Curie, Département de Biopathologie, Paris, France.
  • Gauthier-Villars M; Institut Curie, Inserm U830, Paris, France.
  • Buecher B; Institut Curie, Département de Biopathologie, Paris, France.
  • Bézieau S; Institut Curie, Département de Biopathologie, Paris, France.
  • Stoppa-Lyonnet D; Institut Curie, Département de Biopathologie, Paris, France.
  • Houdayer C; Institut Curie, Département de Biopathologie, Paris, France.
Oncogene ; 35(10): 1324-7, 2016 Mar 10.
Article em En | MEDLINE | ID: mdl-26028024
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias da Mama / Genes BRCA1 / Predisposição Genética para Doença / Genes BRCA2 / Mutação Tipo de estudo: Guideline Limite: Female / Humans / Middle aged Idioma: En Revista: Oncogene Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: França
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias da Mama / Genes BRCA1 / Predisposição Genética para Doença / Genes BRCA2 / Mutação Tipo de estudo: Guideline Limite: Female / Humans / Middle aged Idioma: En Revista: Oncogene Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: França